Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

Nature

Volumn 526, Issue 7571, 2015, Pages 131-135

  Lawson, Devon A ^a,e   Bhakta, Nirav R ^a   Kessenbrock, Kai ^a,b,e   Prummel, Karin D ^a,f   Yu, Ying ^a   Takai, Ken ^a,g   Zhou, Alicia ^b   Eyob, Henok ^b   Balakrishnan, Sanjeev ^b   Wang, Chih Yang ^a,c   Yaswen, Paul ^d   Goga, Andrei ^a,b   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ZURICH   (Switzerland)

^g SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE;

CANCER; CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; GENE EXPRESSION; HOMINID; INHIBITION; MOLECULAR ANALYSIS; MORTALITY; TUMOR;

ADVANCED CANCER; ANIMAL TISSUE; ARTICLE; BREAST METASTASIS; CANCER GROWTH; CANCER STEM CELL; CANCER TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE CELL ANALYSIS; STEM CELL TRANSPLANTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CELL SEPARATION; CELL TRANSFORMATION; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; MESODERM; METABOLISM; NEOPLASM METASTASIS; NONOBESE DIABETIC MOUSE; ONCOGENE MYC; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENES, MYC; HUMANS; MESODERM; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; SINGLE-CELL ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84943143136     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature15260     Document Type: Article

References (33)

1. Weigelt, B., Peterse, J. L. & van't Veer, L. J. Breast cancer metastasis: markers and models. Nature Rev. Cancer 5, 591-602 (2005).
2. Oskarsson, T., Batlle, E. & Massagué, J. Metastatic stemcells: sources, niches, and vital pathways. Cell Stem Cell 14, 306-321 (2014).
3. Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323 (2007).
4. Pang, R. et al. A subpopulation of CD261 cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6, 603-615 (2010).
5. Dieter, S.M. et al. Distinct types of tumor-initiating cells formhuman colon cancer tumors and metastases. Cell Stem Cell 9, 357-365 (2011).
6. Grigoriadis, A. et al. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res. 8, R56 (2006).
7. Jones, C. et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res. 64, 3037-3045 (2004).
8. Kendrick, H. et al. Transcriptome analysis ofmammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMCGenomics 9, 591 (2008).
9. Raouf, A. et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3, 109-118 (2008).
10. Shehata, M. et al. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland. Breast Cancer Res. 14, R134 (2012).
11. Shackleton,M. et al.Generation of a functionalmammary gland froma single stem cell. Nature 439, 84-88 (2006).
12. Stingl, J. et al. Purification andunique properties ofmammary epithelial stemcells. Nature 439, 993-997 (2006).
13. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Med. 15, 907-913 (2009).
14. DeRose, Y. S. et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nature Med. 17, 1514-1520 (2011).
15. Dent, R. et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429-4434 (2007).
16. Malik, N., Canfield, V. A., Beckers, M. C., Gros, P. & Levenson, R. Identification of the mammalian Na,K-ATPase 3 subunit. J. Biol. Chem. 271, 22754-22758 (1996).
17. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
18. Guo,W. et al. SlugandSox9 cooperatively determine themammary stemcell state. Cell 148, 1015-1028 (2012).
19. Landis, M. D., Lehmann, B. D., Pietenpol, J. A. & Chang, J. C. Patient-derived breast tumor xenografts facilitating personalized cancer therapy. Breast Cancer Res. 15, 201 (2013).
20. Cheung, K. J., Gabrielson, E., Werb, Z. & Ewald, A. J. Collective invasion in breast cancer requires a conservedbasal epithelialprogram. Cell155,1639-1651(2013).
21. Bragado, P. et al. TGF-b2 dictates disseminated tumour cell fate in target organs throughTGF-b-RIII andp38a/b signalling.Nature Cell Biol. 15, 1351-1361(2013).
22. Kim, R. S. et al. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PLoS ONE 7, e35569 (2012).
23. Horiuchi, D. et al. MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. J. Exp. Med. 209, 679-696 (2012).
24. Huskey, N. E. et al. CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stemcells, and prevents teratoma formation. Stem Cell Reports 4, 374-389 (2015).
25. Parry, D. et al. Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor. Mol. Cancer Ther. 9, 2344-2353 (2010).
26. Luo, B. et al. Highly parallel identification of essential genes in cancer cells. Proc. Natl Acad. Sci. USA 105, 20380-20385 (2008).
27. Györffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
28. Nguyen-Ngoc, K. V. et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignantmammary epithelium. Proc. Natl Acad. Sci. USA 109, E2595-E2604 (2012).
29. Dalerba, P. et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nature Biotechnol. 29, 1120-1127 (2011).
30. Guo, G. et al. Resolution of cell fate decisions revealed by single-from zygote to blastocyst. Dev. Cell 18, 675-685 (2010).
31. Devonshire, A. S., Elaswarapu, R. & Foy, C. A. Applicability of RNA standards for evaluating RT-qPCR assays and platforms. BMC Genomics 12, 118 (2011).
32. R.Developoment Core Team.A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2012).
33. McDavid, A. et al. Data exploration, quality control and testing in single-cell qPCRbased gene expression experiments. Bioinformatics 29, 461-467 (2013).